3.02
price down icon2.89%   -0.09
after-market Handel nachbörslich: 2.99 -0.03 -0.99%
loading

Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
17.04%
12.77
15.39 11.93 13.34 9.711
Depreciation and Amortization
4.35%
0.154
0.161 0.164 0.18 0.194
Operating Income/Loss
17.04%
-12.77
-15.39 -11.93 -13.34 -9.711
Income/Loss From Continuing Operations Before Tax
19.59%
-10.79
-13.41 -9.964 -11.28 -7.837
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
19.59%
-10.79
-13.41 -9.964 -11.28 -7.837
Net Income/Loss
19.59%
-10.79
-13.41 -9.964 -11.28 -7.837
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
71,799%
136.61
0.19 127.42 126.73 126.38
Basic Earnings Per Share
20.00%
-0.08
-0.10 -0.08 -0.09 -0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Kapitalisierung:     |  Volumen (24h):